Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions.

ABSTRACT: Human papillomavirus (HPV)-related oropharyngeal squamous cell cancer (OPSCC) has emerged as a distinct clinical entity of head and neck cancer with expected high survival. This recognition has led to the investigation of whether a population of patients can be identified who can safely undergo treatment de-escalation, in an effort to minimize long-term treatment toxicity while maintaining excellent survival. The purpose of this review is to describe the rationale for treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials, explore the methods by which risk groups are assigned, and provide context for the multitude of clinical trials that are currently underway.

SUBMITTER: Bigelow EO 

PROVIDER: S-EPMC8035753 | biostudies-literature |

REPOSITORIES: biostudies-literature